Developing a Flow Cytometric Signature of Carfilzomib Responsiveness in Myeloma

Ieuan Walker(King's College London), Michael A. Chapman(Toronto Metropolitan University), Antonio Rodríguez Romera(University of Cambridge), Anna Aubareda(University of Cambridge), William Wilson(Cancer Research UK), Elizabeth H. Phillips(University of Manchester), Daria Galas‐Filipowicz(CRUK Lung Cancer Centre of Excellence), Evelyn Fitzsimons(CRUK Lung Cancer Centre of Excellence), James D. Cavenagh(National Health Service), James P. Roy(University of Cambridge), Tushhar Dadaga(Cancer Research UK), Javier Herrero(London Cancer), Laura Clifton‐Hadley(Cancer Research UK), Kane Foster(London Cancer), Ceri Bygrave(Cardiff and Vale University Health Board), Matthew Streetly(King's College - North Carolina), Gavin Pang(Cancer Research UK), Roger G. Owen(Leeds Teaching Hospitals NHS Trust), Venetia D’arcy(University of Cambridge), Kwee Yong(CRUK Lung Cancer Centre of Excellence), Georgina S.F. Anderson(University of Cambridge), Karthik Ramasamy(Oxford University Hospitals NHS Trust), Rakesh Popat(University College London Hospitals NHS Foundation Trust), Marquita Camilleri(University College London Hospitals NHS Foundation Trust), Sumaiya Kamora(Cancer Research UK), Garima Khandelwal(Cancer Institute (WIA)), Ruth M. de Tute(St James's University Hospital), Selina J Chavda(University College London), Reuben Benjamin(King's College London)
Blood
November 15, 2022
Cited by 0


Related Papers